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Background and Objective: Minor dental surgery is invasive and hemorrhagic. Thus,
in patients treated with anticoagulants, the bleeding risk related to these invasive
procedures is concerning. The aim of this meta-analysis is to evaluate this risk by
comparing the post-operative bleeding rates of oral anticoagulation treatment (OAT)
patients (without interrupted or altered anticoagulant intake) with non-OAT patients.
Methods: PubMed, Embase and the Cochrane Library were searched for eligible
studies that compared the post-operative (following minor dental surgery) bleeding rates
of OAT patients without interrupted or altered therapy with those of non-OAT patients.
Relative risk (RR) and 95% confidence interval (CI) were calculated. Subgroup analyses
were used to identify the association between the bleeding rate and different dental
surgeries or anticoagulants.
Results: Thirty two full text articles were assessed for eligibility and 20 studies were
excluded according to the selection criteria. Finally, 12 studies and a total of 2102 OAT
patients and 2271 non-OAT patients were included. A pooled analysis indicated that
the post-operative bleeding risk in OAT patients is higher than that of non-OAT patients
(RR: 2.794, 95% CI: 1.722–4.532, P = 0.000). The pooled RRs in the dental implant
surgery and dental extraction subgroups were 2.136 (95% CI: 0.825–5.531, P = 0.118)
and 2.003 (95% CI: 0.987–4.063, P = 0.054), respectively. As for the different oral
anticoagulants, the pooled RR in the subgroup of new oral anticoagulants (NOACs)
was 1.603 (95% CI: 0.430–5.980, P = 0.482), while the pooled RR in the vitamin K
antagonists subgroup was 3.067 (95% CI: 1.838–5.118, P = 0.000).
Conclusion: Under current evidence, OAT patients were under a higher post-operative
bleeding risk than the non-OAT patients following minor dental surgery. For the dental
implant surgeries and dental extractions, our study failed to demonstrate a higher risk of
bleeding in the OAT patients compared with the non-OAT patients. Besides, The NOACs
might be safer than the vitamin K antagonists in dental implant surgery. However, more
well-designed studies are required for future research.
Keywords: oral anticoagulants, dental surgery, post-operative hemorrhage, relative risk, patients, meta-analysis
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INTRODUCTION
Oral anticoagulants (OAs) are commonly used in patients with
artificial heart valves, deep vein thrombosis, and pulmonary
embolisms to prevent thromboembolic events (Key and Kasthuri,
2010; Andras et al., 2012; Akin et al., 2015). Most of these
drugs act as vitamin K antagonists, and their mechanism of
action is through inhibition of vitamin K dependent clotting
factors (II, VII, IX, X) (Mackman, 2008; Andras et al., 2012).
In recent years, new oral anticoagulants (NOACs) have emerged
and been used in clinical practice (Ning et al., 2016). Because of
the aging populations and high rates of cardiovascular disease in
most countries, a large number of patients will be undergoing
oral anticoagulant treatment (Madrid and Sanz, 2009; Nocini
et al., 2013). However, although oral anticoagulant treatment
(OAT) with vitamin K antagonists is effective for prophylaxis
of potentially life-threatening thromboembolic events, the risk
of post-operative bleeding has been a concern in the medical
treatment of patients undergoing OAT compared with non-
anticoagulated subjects (Rodríguez-Cabrera et al., 2011; Rowley
et al., 2013; Philip et al., 2014).
According to previous reports (Cannon and Dharmar,
2003; Kämmerer et al., 2015), minor dental surgery, which
is the common procedure in dental health care and routine
outpatient treatment, including tooth extractions, dental implant
surgery, mucoperiosteal flaps, periodontal surgical procedures,
alveoloplasties, limited oral soft tissue surgery, and augmentation
procedures (e.g., elevation of the maxillary sinus). Because most
of these dental operations can be invasive and hemorrhagic,
concern over the safety and efficacy of the OAT and the
accompanying bleeding risks related to these invasive dental
procedures is unavoidable (Pototski and Amenabar, 2007;
Kosyfaki et al., 2011; Jimson et al., 2015). However, clinical
studies evaluating this risk have reported conflicting results. The
results of some studies have revealed that the post-operative
bleeding rate in patients undergoing OAT was not higher
than that in patients not undergoing OAT (Bacci et al., 2010,
2011; Bajkin et al., 2015b). Moreover, using local hemostasis
methods, minor dental surgery can be performed safely in
anticoagulated outpatients, without any modification of their
ongoing anticoagulant therapy. On the contrary, some studies
have reported more post-operative bleeding in OAT patients
(Eichhorn et al., 2012; Iwabuchi et al., 2014), and OAT may
increase the risk of bleeding after these invasive procedures
(Hong et al., 2010).
Furthermore, some systemic reviews have discussed these
clinical problems, but the conclusions of these reviews were also
inconsistent. Two systemic reviews concluded that OAT patients
who continue the OA medication do not have a significantly
higher risk of post-operative bleeding than non-OAT patients
(Madrid and Sanz, 2009; Kämmerer et al., 2015), while Kosyfaki
et al. (2011) thought that the OAT patients are at a higher
risk for enhanced bleeding tendency compared to the non-OAT
patients, when the anticoagulant therapy is continued (Kosyfaki
et al., 2011). Moreover, these systemic reviews did not conduct
a quantitative analysis to validate their conclusions (Madrid and
Sanz, 2009; Kosyfaki et al., 2011; Kämmerer et al., 2015). These
conclusions of clinical studies and systematic reviews indicate
that whether the post-operative bleeding rate is higher in OAT
patients than in the non-OAT patients is need further research.
Because of the special anatomical site of an oral cavity,
severe post-surgical bleeding could lead to serious consequences,
including life-threatening upper airway obstruction, dysphagia,
or post-operative trismus (Evans et al., 2002; Scully and Wolff,
2002; Scully et al., 2007; Kosyfaki et al., 2011). If such events
occur, OAT patients would be more at risk than healthy patients,
which could discourage OAT patients from seeking future dental
treatment (Nematullah et al., 2009). In addition, as patients
increasingly tend to maintain their dental health as they get older,
dentoalveolar surgery is more often indicated for elderly patients
who are taking OAs (Broekema et al., 2014). Therefore, it is of
great importance to evaluate the post-operative bleeding risks
of OAT patients after minor dental surgery and to take effective
hemostatic measures.
Considering that a single study may lack the power to
provide reliable conclusion due to the small number of subjects,
and lack of quantitative analysis in the available systemic
reviews, a meta-analysis is required to quantitatively assess the
risk. Therefore, we conducted this meta-analysis by collecting
available evidences, which comparing the post-operative (i.e.,
minor dental surgery) bleeding rates of OAT patients without
interruptions or modifications to their therapy with those of non-
OAT patients, to evaluate the post-operative bleeding risk of
OAT. These results will provide clinicians with better evidence-
based evaluations and recommendations.
MATERIALS AND METHODS
Search Strategy and Selection Criteria
In this meta-analysis, we included clinical studies that compared
the post-operative bleeding rates (following minor dental
surgery) of OAT patients without interrupted or altered
therapy and non-OAT patients. Studies with available data
that could be extracted were also included. The post-operative
bleeding events include: slight bleeding and moderate bleeding,
and severe hemorrhaging. The exclusion criteria were (1)
animal studies or in vitro studies, (2) reviews, case reports
or comments, (3) studies without available data that could
be extracted, and (4) studies with patients who were also
being treated with antiplatelet drugs or undergoing major
surgery.
We searched PubMed, Embase for related studies published
from January 1985 to December 2016, and the language was
restricted to English. Then, we searched the Cochrane Library,
without restrictions. The combination of the following keywords
was used: “oral anticoagulant,” “oral anticoagulation treatment
(OAT),” “bleeding,” and “dental surgery.” Additional studies were
identified by manual searches of the reference lists of the related
articles and reviews. These results were independently assessed by
two reviewers (SQ and XJ), and any disagreement was resolved
through discussion with a third reviewer (LHC).
Briefly, based on the inclusion criteria, the studies were
selected as follows. First, after eliminating duplicate articles,
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FIGURE 1 | A flowchart of the retrieved studies. OAT, oral anticoagulation treatment.
irrelevant records were excluded by reading the titles and
abstracts. Then, full-texts of the potential studies were scanned,
and only the studies meeting the inclusion criteria were ultimately
included in our meta-analysis.
Data Extraction and Quality Assessment
The following information was extracted from each included
study: the study ID (first author and year of publication), study
design, type of dental surgery, characteristics of the subjects
(including the number of patients in each group, age range,
sex, oral anticoagulant therapy in the OAT group, and number
of patients with post-operative bleeding), hemostasis protocol,
and follow-up time, as well as a brief conclusion from study.
This process was independently performed by two reviewers
(SQ and XJ).
The quality assessment was completed by two reviewers
(ZT and ZB) using the Newcastle-Ottawa Scale (NOS). In
this assessment tool, the study selection, comparability, and
outcomes are used to appraise the methodological quality of
the included studies, with a maximum of nine points for
each study (Wells et al., 2013). NOS scores of 1–3, 4–6,
and 7–9 indicated low, moderate, and high study quality,
respectively.
Data Synthesis and Analysis
Comprehensive Meta-Analysis software package (Version 2.0;
Biostat) was used to perform the meta-analysis. The relative
risk (RR) and 95% confidence interval (CI) were pooled to
estimate the risk of post-operative bleeding in the OAT patients
compared with the non-OAT patients. Heterogeneity between
studies was tested using I2 statistics (I2 values of 25, 50, and
75% were considered low, moderate, and high, respectively).
A fixed effects model was used if the heterogeneity was
low; otherwise, a random effects model was used. Sensitivity
analysis and cumulative analysis was performed to analysis the
stability of the pooled results. Subgroup analyses of the different
dental surgeries and different oral anticoagulants were also
performed.
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TABLE 1 | Summary of the included studies.
Study ID Study design Dental surgery Oral anticoagulant therapy Follow up
time
NOS score
Febbo A 2016 Retrospective Dental extraction Patients were treated with vitamin
warfarin and INR less than 4
Day 1 to day 10 7
Gómez-Moreno G 2016b Prospective Dental implant surgery Patients had been taking dabigatran for
over 6 months (150 mg orally every
12 h).
Days 3, 8 8
Gómez-Moreno G 2016a Prospective Dental implant surgery Patients had been treated with
rivaroxaban for over 6 month
Days 3, 8 8
Clemm R 2016 Prospective Dental implant surgery Patients were treated with vitamin K
inhibitors or direct oral anticoagulants.
Day 10 7
Bajkin BV 2015 Prospective Dental extraction, apicectomy, etc. Patients were treated with vitamin K
antagonists and INR: 2.0–4.2
Days 1, 2, 5, 7 7
Broekema FI 2014 Prospective Dental extraction, apicectomy, dental
implant surgery
Patients were treated with vitamin K
antagonists and INR: 1.8–3.5.
1 week 7
Eichhorn W 2012 Retrospective Osteotomies, apicoectomies,
extractions, etc.
Patients were treated with coumarins,
INR : 1.2- 4.2
Days 1, 7, 10,
14
5
Karslı ED 2011 Prospective Dental extraction Patients on warfarin treatment without
interruption,
INR < 4.0
48 h 6
Bacci C 2011 Prospective Dental implant surgery INR: 1.8–2.98; warfarin therapy
>6 months; normal hemoglobin value
and platelet count
Days 3, 8 8
Bacci C 2010 Prospective Dental extraction Patients were treated with warfarin for
at least 3 months, and the therapy was
maintained unchanged. INR: 1.8–4
Days 3, 8 8
Zanon E 2003 Prospective Dental extraction Patients on warfarin without changed.
INR: 1.8–4
Days 3, 8 7
Campbell JH 2000 Prospective Extraction, alveoloplasty, intraoral soft
tissue surgery
Patients continued their anticoagulant
regimens. INR:1.2–2.9
Day 1 5
INR, international normalized ratio.
RESULTS
Study Selection
Initially, 613 papers were identified through our search strategy.
We reviewed 32 papers in full-text, 14 of which did not have
a non-OAT group or a continued OAT group (Al-Mubarak
et al., 2006; Hong et al., 2010, 2012; Somma et al., 2010;
Morimoto et al., 2011; Bajkin and Todorovic, 2012; Hamid
et al., 2012; Healey et al., 2012; Ermer et al., 2013; Svensson
et al., 2013; Abdullah and Khalil, 2014; Bajkin et al., 2015a;
Dudek et al., 2016; Zirk et al., 2016); two studies aimed to
evaluate the local hemostatic effect of drugs (Al-Belasy and
Amer, 2003; Cakarer et al., 2013); one study included the
patients with antiplatelet therapy, and data was collected by
tooth instead by patient (Iwabuchi et al., 2014); two were
meeting abstracts and the data overlapped with other studies
(Broekema et al., 2013; Febbo et al., 2015); and in the last
study, the OAT patients skipped the OA before the dental
surgery (Miclotte et al., 2016). Eventually, 12 studies (Campbell
et al., 2000; Zanon et al., 2003; Bacci et al., 2010, 2011; Karslı
et al., 2011; Eichhorn et al., 2012; Broekema et al., 2014; Bajkin
et al., 2015b; Clemm et al., 2016; Febbo et al., 2016; Gómez-
Moreno et al., 2016a,b) were included in our meta-analysis.
A flow diagram of the study selection process is shown in
Figure 1.
Summary of the Included Studies
The publication dates of the 12 included studies ranged from
2000 to 2016. Ten studies (Campbell et al., 2000; Zanon et al.,
2003; Bacci et al., 2010, 2011; Karslı et al., 2011; Broekema et al.,
2014; Bajkin et al., 2015b; Clemm et al., 2016; Gómez-Moreno
et al., 2016a,b) are prospective studies and two are retrospective
studies (Eichhorn et al., 2012; Febbo et al., 2016). Four studies
(Bacci et al., 2011; Clemm et al., 2016; Gómez-Moreno et al.,
2016a,b) researched dental implants in OAT patients, and four
studies (Zanon et al., 2003; Bacci et al., 2010; Karslı et al., 2011;
Febbo et al., 2016) focused on dental extractions. In the last four
studies (Campbell et al., 2000; Eichhorn et al., 2012; Broekema
et al., 2014; Bajkin et al., 2015b) the surgeries included dental
extraction, apicoectomy, dental implant surgery, limited intraoral
soft tissue surgery, and so on. All OAT patients maintained
their anticoagulation medication therapies. The value of the
international normalized ratio (INR) in the included studies was
less than 4.2 (Table 1). To stop the intraoperative and post-
operative bleeding, all studies adopted local hemostatic measures.
These measures and main conclusions of the included studies can
be found in the Supplementary Table A1.
The quality assessment results are shown in Table 1, using the
NOS. Nine studies (Zanon et al., 2003; Bacci et al., 2010, 2011;
Broekema et al., 2014; Bajkin et al., 2015b; Clemm et al., 2016;
Febbo et al., 2016; Gómez-Moreno et al., 2016a,b) scored more
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TABLE 2 | Patient characteristics and post-operative bleeding rates in the included studies.
Study ID OAT group Non-OAT group
Total number
(male/female)
Age
(mean ± SD)
Number
of
bleeding
cases
Rate Total number
(male/female)
Age
(mean ± SD)
Number of
bleeding
cases
Rate
Febbo A 2016 439 (278/161) 69.53a 9 2.05% 439 (234/205) 65.19 a 0 0%
Gómez-Moreno G 2016b 29 (19/10) 49–71
(66.7 ± 9.15)
2 6.90% 42 NR 2 4.76%
Gómez-Moreno G 2016a 18 (12/6) 46–73
(64.4 ± 7.84)
1 5.56% 39 NR 2 5.13%
Clemm R 2016 46b NR 2 4.35% 447 NR 3 0.67%
Bajkin BV 2015 125 (81/44) 65.6 ± 9.83 7 5.60% 85 (52/33) 64.5 ± 9.8 1 1.18%
Broekema FI 2014 32b NR 3 9.38% 103 (68/35) 21–85 2 1.94%
Eichhorn W 2012 637 (423/214) 26–93
(68 ± 12.1)
47 7.38% 285 (138/147) 23–88
(64 ± 10.3)
2 0.70%
Karslı ED 2011 13 (7/6) 32–69
(46.2 ± 11)
6c 46.15% 13 (7/6) 29–61
(40.38 ± 9.23)
3 c 23.08%
Bacci C 2011 52d (39/13) 41–77
(56.2 ± 8.88)
2 3.85% 109 NR 3 2.75%
Bacci C 2010 451 (246/205) 38–89 63.5a 7 1.55% 449 (202/247) 35–92 66.4a 4 0.89%
Zanon E 2003 250 (59/191) 44–88 4 1.60% 250 (84/166) 42–92 3 1.20%
Campbell JH 2000 12 NR 1 8.33% 10 NR 0 0%
Total 2102 91 4.33% 2271 25 1.10%
aMean age of the patients; bdata from the OAT group were a subgroup in the original research; c in this study, the patients who used extra gauze swabs during the first
48 h for bleeding control were counted; dtwo patients were excluded in the final analysis. NR, not reported.
than seven points and were considered to be of high quality.
Three studies (Campbell et al., 2000; Karslı et al., 2011; Eichhorn
et al., 2012) scored less than six points and were considered to be
of moderate quality. No studies were found with low quality.
From these included studies, a total of 2271 non-OAT
patients and 2102 OAT patients were studied. Twenty-five
of the non-OAT patients presented with post-operative
bleeding, and the total bleeding rate was 1.10%. In the
OAT group, 91 patients presented with post-operative
bleeding, and the total bleeding rate was 4.33%, which
was higher than that in the non-OAT group (Table 2).
Totally, two OAT patients in two studies developed a severe
bleeding and needed to be hospitalized (Supplementary
Table A1).
FIGURE 2 | Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients. RR, relative risk; CI, confidence
interval.
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FIGURE 3 | Forest plot of the sensitivity analysis performed by sequential removing single studies. RR, relative risk; CI, confidence interval.
FIGURE 4 | Forest plot of the cumulative meta-analysis by publication year. RR, relative risk; CI, confidence interval.
FIGURE 5 | Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients in the dental extraction
subgroup. RR, relative risk; CI, confidence interval.
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FIGURE 6 | Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients in the dental implant subgroup.
RR, relative risk; CI, confidence interval.
FIGURE 7 | Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients in the mixed surgery subgroup.
RR, relative risk; CI, confidence interval.
FIGURE 8 | Forest plot of the post-operative bleeding risk comparison between patients treated with vitamin K antagonists and non-OAT patients.
RR, relative risk; CI, confidence interval.
Meta-analysis
Primary Outcomes
A meta-analysis of the post-operative bleeding rate in the
OAT and non-OAT groups was performed. The pooled
RR and 95% CI for the OAT patients versus non-OAT
patients was 2.794 (95% CI: 1.722–4.532), and this difference
was statistically significant (P = 0.000, Figure 2). The I2
value was 0, therefore, heterogeneity between the included
studies was low, and a fixed effects model was selected.
The sensitivity analysis performed by sequentially removing
individual studies revealed stable and statistically significant
results (Figure 3). Furthermore, a cumulative analysis performed
by the order of publication date showed that with overlay of
numbers of studies and patients, the results tend to be stable
(Figure 4)
Secondary Outcomes
Figures 5–7 show the subgroup analysis results of the
different minor dental surgeries. For dental implant surgery
and dental extraction, the pooled RRs were 2.136 (95% CI:
0.825–5.531, fixed effect model, I2 = 0, Figure 6) and 2.003
(95% CI: 0.987–4.063, fixed effect model, I2 = 0, Figure 5),
respectively. The results indicated no significant difference
between the dental implant surgery and dental extraction
subgroups (P = 0.118 and P = 0.054, respectively). The final
studies were composed of mixed dental surgeries, and the
pooled RR was 6.361 (95% CI: 2.522–16.040, fixed effect model,
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I2 = 0), which indicated a significant difference (P = 0.000,
Figure 7).
The OAT patients in nine studies (Campbell et al., 2000;
Zanon et al., 2003; Bacci et al., 2010, 2011; Karslı et al., 2011;
Eichhorn et al., 2012; Broekema et al., 2014; Bajkin et al.,
2015b; Febbo et al., 2016) were being treated with vitamin K
antagonists, and two studies focused on rivaroxaban (Gómez-
Moreno et al., 2016a) and dabigatran (Gómez-Moreno et al.,
2016b), which belong to the NOACs group. Both of these two
types of anticoagulants were extracted from the (Clemm et al.,
2016) study through our meta-analysis. In the NOACs subgroup,
the pooled RR was 1.603 (95% CI: 0.430–5.980), which failed to
show that treatment with NOACs increased the post-operative
bleeding rate compared with non-OAT patients (P = 0.482,
I2 = 0, fixed effects model, Figure 8). In the subgroup of vitamin
K antagonists, the pooled RR was 3.067 (95% CI: 1.838–5.118),
which was a significant difference (P = 0.000, I2 = 0, fixed effect
model). These results are shown in Figure 9.
DISCUSSION
The question about discontinued, reducing or maintaining
before minor dental surgeries has been a controversial subject.
A definitive, standardized protocol for managing minor dental
surgery in anticoagulated patients is still lacking (Bacci et al.,
2010). It was suggested that OAT patients (INR 2–4) who
continued their anticoagulants do not have a significantly higher
risk of post-operative bleeding than non-OAT patients (Madrid
and Sanz, 2009). However, some reviews concluded that more
minor bleedings might occur in OAT patients and that the use
of local hemostatic measures, as well as close and extended post-
operative monitoring, is vital (Gacina et al., 2006; Kämmerer
et al., 2015). Nevertheless, these reviews only had carried on the
qualitative description without quantitative analysis. Therefore, it
is still disputed whether OAT would increase the post-operative
bleeding risk following minor dental surgery, an invasive and
hemorrhagic procedure. Our meta-analysis focused on this
question, and we performed a quantitative analysis to evaluate
the risk by comparing the post-operative bleeding rates of OAT
patients without interrupted or altered anticoagulant use and
non-OAT patients.
Based on our search strategy and selection criteria, 12 studies
(Campbell et al., 2000; Zanon et al., 2003; Bacci et al., 2010,
2011; Karslı et al., 2011; Eichhorn et al., 2012; Broekema et al.,
2014; Bajkin et al., 2015b; Clemm et al., 2016; Gómez-Moreno
et al., 2016a,b) were included in our meta-analysis. The post-
operative bleeding rate in the OAT group (4.32%) was higher
than that in the non-OAT group (1.10%). The pooled RR for
the OAT patients versus the non-OAT patients was 2.794 (95%
CI: 1.722–4.532), and the difference was statistically significant,
which indicates that OAT will increase the risk of post-operative
bleeding following minor dental surgery. Furthermore, sensitivity
analysis performed by sequentially removing individual studies
did not change the results. To stop the bleeding, all included
studies used local hemostatic methods after the dental surgeries,
while only two OAT patients in two studies developed a severe
bleeding and needed to be hospitalized (Clemm et al., 2016; Febbo
et al., 2016). Evidence from the current analysis suggested that
following minor dental surgery, patients who were treated with
oral anticoagulants might have a higher post-operative bleeding
risk compared with non-OAT patients, which differs from the
previous systematic review (Madrid and Sanz, 2009). Fortunately,
using careful local hemostatic methods, the bleeding can be
stopped effectively.
As previously mentioned, the value of heterogeneity between
studies was tested using I2 statistics. A fixed effects model was
used if the heterogeneity was low; otherwise, a random effects
model was used. We know that when the heterogeneity is low,
a fixed model will give us a more reliable result. While when the
heterogeneity was high, subgroup analysis will be made to explore
the source of heterogeneity. Despite the overall heterogeneity
was low in this study, we had still made the subgroup analysis.
Here are the reasons: first, minor dental surgery is not a single
FIGURE 9 | Forest plot of the post-operative bleeding risk comparison between patients treated with NOACs and non-OAT patients. RR, relative risk;
CI, confidence interval.
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operation and it includes several types of surgeries; OAs are also
composed of several kinds of drugs. The most common OAs,
vitamin K antagonists and NOACs, have different mechanism of
action. Therefore, we want to identify the association between the
bleeding rate and different dental surgeries or anticoagulants to
give more guidance for clinicians.
Because the category of minor dental surgery includes several
types of surgeries, we performed a subgroup analysis to evaluate
the post-operative bleeding risk in the different minor dental
surgeries in the included studies. Dental implants are generally
considered effective and reliable restorations to replace lost teeth
and to restore masticatory function (Shi et al., 2016), and they
have been increasingly accepted by patients. Four studies (Bacci
et al., 2011; Clemm et al., 2016; Gómez-Moreno et al., 2016a,b)
focused on dental implant surgery, and the subgroup meta-
analysis revealed that the pooled RR was 2.136 (95% CI: 0.825–
5.531), with no significant difference (P = 0.17). Four studies
(Zanon et al., 2003; Bacci et al., 2010; Karslı et al., 2011; Clemm
et al., 2016) focused on dental extractions, one of the most
common dental surgeries, and the results of the subgroup meta-
analysis (pooled RR: 2.003, 95% CI: 0.987–3.063, P = 0.054)
was similar to the dental implant subgroup meta-analysis. The
results might indicate that with strong local hemostatic measures,
the post-operative bleeding risk of OAT patients is not higher
than that of non-OAT patients. The operations in the other four
studies (Campbell et al., 2000; Eichhorn et al., 2012; Broekema
et al., 2014; Bajkin et al., 2015b) were mixed (i.e., several dental
surgeries). However, the results reveal that the pooled RR was
6.361 (95% CI: 2.522–16.040, P = 0.000), indicating that the
bleeding risk of the OAT patients was high. Considering the
heterogeneity of the surgeries in these three studies, more studies
that focus on single surgeries will be needed in the future. Despite
the level of evidence about what extent a safe and successful
dental treatment in OAT patients is feasible was lacking (Kosyfaki
et al., 2011), however, the intraoperative operation must be as
atraumatic as possible to reduce post-operative bleeding.
Vitamin K antagonists (e.g., warfarin) are commonly used
in patients with artificial heart valves, deep vein thrombosis,
etc. (Key and Kasthuri, 2010; Andras et al., 2012; Cocco et al.,
2016). According to the guidelines developed at the Academic
Centre for Dentistry Amsterdam (ACTA), the INR of the patients
taking vitamin K antagonists (which is measured within 24–72 h
preoperatively) must be≤3.5 (Broekema et al., 2014). While other
studies have reported that an INR < 4 was a safe range prior
to dental surgery (Evans et al., 2002; Bacci et al., 2011; Karslı
et al., 2011; Jimson et al., 2015). The INR value was less than
4.2 in nine of the included studies in which the OAT patients
were being treated with vitamin K antagonists. The pooled RR
in the vitamin K antagonists subgroup analysis was 3.067 (95%
CI: 1.838–5.118, P = 0.000), indicating that under the current
range, the bleeding rate of the patients treated with vitamin
K antagonists was higher than that of the non-OAT patients.
However, in the subgroup of NOACs, the pooled RR was 1.603
(95% CI: 0.430–5.980, P = 0.482). Based on the two opposite
pooled analysis results above, we may conclude that The NOACs
might be safer than the vitamin K antagonists in minor dental
surgery. Furthermore, the patients treated with NOACs in these
three studies underwent dental implant surgery, hence the results
of the subgroup analysis indicated that the NOACs might be safer
than the vitamin K antagonists for dental implant surgery. Our
conclusion was similar to that of Gómez-Moreno et al. (2016a),
who reported that implant insertion surgery has been made safer
and easier, and does not require special monitoring for patients
being treated with these new anticoagulants (Gómez-Moreno
et al., 2016a). However, considering the limited number of studies
in the subgroup of NOACs and the lacking of direct evidence that
compared the vitamin K antagonists and NOACs, more studies
are required in the future.
To our knowledge, this is the first meta-analysis to estimate the
association between OAT and post-operative bleeding following
minor dental surgery by quantitative analysis, especially grouped
by different dental surgeries and different oral anticoagulants.
Not only did we research electronic databases to identify
potential interests, but also we manually examined reference
lists from relevant studies. The NOS assessment tool was
used to evaluate each of the included studies and none of
them had low quality. In the meta-analysis and subgroup
analyses, the included studies had low heterogeneity, which
significantly increased the statistical power of our analysis.
Moreover, sensitivity and cumulative analyses were performed
to determine the stability of the pooled results. However,
our meta-analysis has three limitations. First, although the
included studies had low heterogeneity, the types of surgery
and the oral anticoagulants used differed. Second, the search
was limited to English-language studies, which might have
introduced selection bias to this meta-analysis. Third, because
of limit information provided by the included studies, we
did not explore the bleeding risk of OAT patients by
controlling for factor affecting bleeding risk such as INR
value.
In summary, the following conclusions were made: (1)
The OAT patients had a higher post-operative bleeding risk
than the non-OAT patients following minor dental surgery,
and the local hemostatic methods effectively stopped the
bleeding; (2) For the dental implant surgeries and dental
extractions, our study failed to demonstrate a higher risk
of bleeding in the OAT patients compared with the non-
OAT patients; (3) The NOACs might be safer than the
vitamin K antagonists in dental implant surgery. The present
meta-analysis will give clinical doctors a better understanding
of the risks of post-operative bleeding in OAT patients
after minor dental surgery and help patients make rational
decisions. Besides, more well-designed studies with adequate
controls for confounding factors are required for future
research.
AUTHOR CONTRIBUTIONS
The sections on literature research, study selection and data
extraction were completed by QS and JX; the section on risk
of bias evaluation and data analysis were completed by TZ and
BZ; QS drafted the manuscript and JX helped to revise the
manuscript. HL is the corresponding author, and he undertook
Frontiers in Pharmacology | www.frontiersin.org 9 February 2017 | Volume 8 | Article 58
fphar-08-00058 February 6, 2017 Time: 12:1 # 10
Shi et al. Post-operative Bleeding Risk in OAT-Patients
the work of designing this meta-analysis, coordinating and
helping to draft the manuscript. All authors read and approved
the final manuscript.
FUNDING
This study was supported in part by grants from the
National High Technology Research and Development Program
(“863”Program) of China (2015AA033502) and the National
Natural Science Foundation of China (No. 81271180).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fphar.
2017.00058/full#supplementary-material
REFERENCES
Abdullah, W. A., and Khalil, H. (2014). Dental extraction in patients on warfarin
treatment. Clin. Cosmet. Investig. Dent. 6, 65–69. doi: 10.2147/CCIDE.S68641
Akin, M., Schafer, A., Akin, I., Widder, J., and Brehm, M. (2015). Use of new oral
anticoagulants in the treatment of venous thromboembolism and thrombotic
prophylaxis. Cardiovasc. Hematol. Disord. Drug Targets 15, 92–96. doi: 10.2174/
1871529X1502151209110620
Al-Belasy, F. A., and Amer, M. Z. (2003). Hemostatic effect of n-butyl-2-
cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral
surgery. J. Oral Maxillofac. Surg. 61, 1405–1409. doi: 10.1016/j.joms.2002.12.001
Al-Mubarak, S., Rass, M. A., Alsuwyed, A., Alabdulaaly, A., and Ciancio, S.
(2006). Thromboembolic risk and bleeding in patients maintaining or stopping
oral anticoagulant therapy during dental extraction. J. Thromb. Haemost. 4,
689–691. doi: 10.1111/j.1538-7836.2006.01825.x
Andras, A., Sala Tenna, A., and Crawford, F. (2012). Vitamin K antagonists or low-
molecular-weight heparin for the long term treatment of symptomatic venous
thromboembolism. Cochrane Database Syst. Rev. 10:Cd002001. doi: 10.1002/
14651858.CD002001.pub2
Bacci, C., Berengo, M., Favero, L., and Zanon, E. (2011). Safety of dental implant
surgery in patients undergoing anticoagulation therapy: a prospective case-
control study. Clin. Oral Implants Res. 22, 151–156. doi: 10.1111/j.1600-0501.
2010.01963.x
Bacci, C., Maglione, M., Favero, L., Perini, A., Di Lenarda, R., Berengo, M., et al.
(2010). Management of dental extraction in patients undergoing anticoagulant
treatment. Results from a large, multicentre, prospective, case-control study.
Thromb. Haemost. 104, 972–975. doi: 10.1160/TH10-02-0139
Bajkin, B. V., and Todorovic, L. M. (2012). Safety of local anaesthesia in dental
patients taking oral anticoagulants: Is it still controversial? Br. J. Oral Maxillofac.
Surg. 50, 65–68. doi: 10.1016/j.bjoms.2010.11.002
Bajkin, B. V., Urosevic, I. M., Stankov, K. M., Petrovic, B. B., and Bajkin, I. A.
(2015a). Dental extractions and risk of bleeding in patients taking single and
dual antiplatelet treatment. Br. J. Oral Maxillofac. Surg. 53, 39–43. doi: 10.1016/
j.bjoms.2014.09.009
Bajkin, B. V., Vujkov, S. B., Milekic, B. R., and Vuckovic, B. A. (2015b). Risk
factors for bleeding after oral surgery in patients who continued using oral
anticoagulant therapy. J. Am. Dent. Assoc. 146, 375–381. doi: 10.1016/j.adaj.
2015.01.017
Broekema, F. I., Van Minnen, B., Jansma, J., and Bos, R. (2013). Risk of rebleeding
after dentoalveolar surgery in patients on anticoagulant therapy compared to
patients without anticoagulant therapy. Int. J. Oral Maxillofac. Surg. 42:1238.
Broekema, F. I., Van Minnen, B., Jansma, J., and Bos, R. R. (2014). Risk of
bleeding after dentoalveolar surgery in patients taking anticoagulants. Br. J. Oral
Maxillofac. Surg. 52, e15–e19. doi: 10.1016/j.bjoms.2014.01.006
Cakarer, S., Eyupoglu, E., Gunes, C., Kuseoglu, B. G., Berberoglu, H. K., and
Keskin, C. (2013). Evaluation of the hemostatic effects of ankaferd blood stopper
during dental extractions in patients on antithrombotic therapy. Clin. Appl.
Thromb. Hemost. 19, 96–99. doi: 10.1177/1076029611435836
Campbell, J. H., Alvarado, F., and Murray, R. A. (2000). Anticoagulation and minor
oral surgery: Should the anticoagulation regimen be altered? J. Oral Maxillofac.
Surg. 58, 131–135; discussion 135–136. doi: 10.1016/S0278-2391(00)90324-0
Cannon, P. D., and Dharmar, V. T. (2003). Minor oral surgical procedures in
patients on oral anticoagulants–a controlled study. Aust. Dent. J. 48, 115–118.
doi: 10.1111/j.1834-7819.2003.tb00019.x
Clemm, R., Neukam, F. W., Rusche, B., Bauersachs, A., Musazada, S., and Schmitt,
C. M. (2016). Management of anticoagulated patients in implant therapy: a
clinical comparative study. Clin. Oral Implants Res. 27, 1274–1282. doi: 10.1111/
clr.12732
Cocco, G., Amiet, P., and Jerie, P. (2016). Antithromboembolic strategies in atrial
fibrillation: a review. Cardiol. J. 23, 211–223. doi: 10.5603/CJ.a2016.0004
Dudek, D., Marchionni, S., Gabriele, M., Iurlaro, A., Helewski, K., Toti, P., et al.
(2016). Bleeding rate after tooth extraction in patients under oral anticoagulant
therapy. J. Craniofac. Surg. 27, 1228–1233. doi: 10.1097/SCS.00000000000
02713
Eichhorn, W., Burkert, J., Vorwig, O., Blessmann, M., Cachovan, G., Zeuch, J.,
et al. (2012). Bleeding incidence after oral surgery with continued oral
anticoagulation. Clin. Oral Investig. 16, 1371–1376. doi: 10.1007/s00784-011-
0649-1
Ermer, M., Voss, P. J., Bittermann, G., Metzger, M. C., and Schmelzeisen, R. (2013).
Post operative bleeding in dentoalveolar surgery—a 6 years retrospective
analysis. Int. J. Oral Maxillofac. Surg. 42:1239. doi: 10.1016/j.ijom.2013.07.236
Evans, I. L., Sayers, M. S., Gibbons, A. J., Price, G., Snooks, H., and Sugar,
A. W. (2002). Can warfarin be continued during dental extraction? Results
of a randomized controlled trial. Br. J. Oral Maxillofac. Surg. 40, 248–252.
doi: 10.1054/bjom.2001.0773
Febbo, A., Cheng, A., Goss, A. N., Stein, M., and Sambrook, P. J. (2015).
Postoperative bleeding following dental extractions in warfarinised patients.
Int. J. Oral Maxillofac. Surg. 44:e207. doi: 10.1016/j.ijom.2015.08.076
Febbo, A., Cheng, A., Stein, B., Goss, A., and Sambrook, P. (2016).
Postoperative bleeding following dental extractions in patients anticoagulated
with warfarin. J. Oral Maxillofac. Surg. 74, 1518–1523. doi: 10.1016/j.joms.2016.
04.007
Gacina, P., Caržavec, D., Stancic, V., and Pejsa, V. (2006). Dental procedures in
patients receiving oral anticoagulant therapy. Acta Clin. Croat. 45, 101–104.
Gómez-Moreno, G., Aguilar-Salvatierra, A., Fernandez-Cejas, E., and Delgado-
Ruiz, R. A. (2016a). Dental implant surgery in patients in treatment with the
anticoagulant oral rivaroxaban. Clin. Oral Implants Res. 27, 730–733. doi: 10.
1111/clr.12653
Gómez-Moreno, G., Fernandez-Cejas, E., Aguilar-Salvatierra, A., De Carlos, F., and
Delgado-Ruiz, R. A. (2016b). Dental implant surgery in patients in treatment
by dabigatran. Clin. Oral Implants Res. doi: 10.1111/clr.12785 [Epub ahead of
print].
Hamid, B., Wacila, Z., and Fadé La, D. (2012). “Minor oral surgeries and teeth
extractions in patients taking antivitamin k and antiplatelet drugs: a prospective
study about 940 acts and a literature review,” in Proceedings of the World
Congress of Cardiology Scientific Sessions, Vol. 125, Dubai.
Healey, J. S., Eikelboom, J., Douketis, J., Wallentin, L., Oldgren, J., Yang, S., et al.
(2012). Periprocedural bleeding and thromboembolic events with dabigatran
compared with warfarin: results from the randomized evaluation of long-term
anticoagulation therapy (RE-LY) randomized trial. Circulation 126, 343–348.
doi: 10.1161/CIRCULATIONAHA.111.090464
Hong, C., Napenas, J. J., Brennan, M., Furney, S., and Lockhart, P. (2012). Risk
of postoperative bleeding after dental procedures in patients on warfarin: a
retrospective study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 114, 464–468.
doi: 10.1016/j.oooo.2012.04.017
Hong, C. H., Napenas, J. J., Brennan, M. T., Furney, S. L., and Lockhart, P. B.
(2010). Frequency of bleeding following invasive dental procedures in patients
on low-molecular-weight heparin therapy. J. Oral Maxillofac. Surg. 68, 975–979.
doi: 10.1016/j.joms.2009.09.054
Iwabuchi, H., Imai, Y., Asanami, S., Shirakawa, M., Yamane, G. Y., Ogiuchi, H.,
et al. (2014). Evaluation of postextraction bleeding incidence to compare
patients receiving and not receiving warfarin therapy: a cross-sectional,
Frontiers in Pharmacology | www.frontiersin.org 10 February 2017 | Volume 8 | Article 58
fphar-08-00058 February 6, 2017 Time: 12:1 # 11
Shi et al. Post-operative Bleeding Risk in OAT-Patients
multicentre, observational study. BMJ Open 4:e005777. doi: 10.1136/bmjopen-
2014-005777
Jimson, S., Amaldhas, J., Jimson, S., Kannan, I., and Parthiban, J. (2015).
Assessment of bleeding during minor oral surgical procedures and extraction
in patients on anticoagulant therapy. J. Pharm. Bioallied Sci. 7, S134–S137.
doi: 10.4103/0975-7406.155862
Kämmerer, P. W., Frerich, B., Liese, J., Schiegnitz, E., and Al-Nawas, B. (2015).
Oral surgery during therapy with anticoagulants-a systematic review. Clin. Oral
Investig. 19, 171–180. doi: 10.1007/s00784-014-1366-3
Karslı, E. D., Erdogan, O., Esen, E., and Acarturk, E. (2011). Comparison of the
effects of warfarin and heparin on bleeding caused by dental extraction: a
clinical study. J. Oral Maxillofac. Surg. 69, 2500–2507. doi: 10.1016/j.joms.2011.
02.134
Key, N. S., and Kasthuri, R. S. (2010). Current treatment of venous
thromboembolism. Arterioscler. Thromb. Vasc. Biol. 30, 372–375. doi: 10.1161/
ATVBAHA.109.197145
Kosyfaki, P., Att, W., and Strub, J. R. (2011). The dental patient on oral
anticoagulant medication: a literature review. J. Oral Rehabil. 38, 615–633.
doi: 10.1111/j.1365-2842.2010.02184.x
Mackman, N. (2008). Triggers, targets and treatments for thrombosis. Nature 451,
914–918. doi: 10.1038/nature06797
Madrid, C., and Sanz, M. (2009). What influence do anticoagulants have on oral
implant therapy? A systematic review. Clin. Oral Implants Res. 20(Suppl. 4),
96–106. doi: 10.1111/j.1600-0501.2009.01770.x
Miclotte, I., Vanhaverbeke, M., Agbaje, J. O., Legrand, P., Vanassche, T.,
Verhamme, P., et al. (2016). Pragmatic approach to manage new oral
anticoagulants in patients undergoing dental extractions: a prospective case-
control study. Clin. Oral Investig. doi: 10.1007/s00784-016-2010-1 [Epub ahead
of print].
Morimoto, Y., Niwa, H., and Minematsu, K. (2011). Risk factors affecting
postoperative hemorrhage after tooth extraction in patients receiving oral
antithrombotic therapy. J. Oral Maxillofac. Surg. 69, 1550–1556. doi: 10.1016/
j.joms.2010.10.018
Nematullah, A., Alabousi, A., Blanas, N., Douketis, J. D., and Sutherland,
S. E. (2009). Dental surgery for patients on anticoagulant therapy with
warfarin: a systematic review and meta-analysis. J. Can. Dent. Assoc.
75:41.
Ning, G. Z., Kan, S. L., Chen, L. X., Shangguan, L., Feng, S. Q., and Zhou, Y. (2016).
Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a
meta-analysis with trial sequential analysis of randomized controlled trials. Sci.
Rep. 6:23726. doi: 10.1038/srep23726
Nocini, P. F., Castellani, R., Zanotti, G., Bertossi, D., Luciano, U., and De
Santis, D. (2013). The use of computer-guided flapless dental implant surgery
(NobelGuide) and immediate function to support a fixed full-arch prosthesis
in fresh-frozen homologous patients with bone grafts. J. Craniofac. Surg. 24,
e551–e558. doi: 10.1097/SCS.0b013e31829ac8e2
Philip, I., Berroeta, C., and Leblanc, I. (2014). Perioperative challenges of
atrial fibrillation. Curr. Opin. Anaesthesiol. 27, 344–352. doi: 10.1097/ACO.
0000000000000070
Pototski, M., and Amenabar, J. M. (2007). Dental management of patients receiving
anticoagulation or antiplatelet treatment. J. Oral Sci. 49, 253–258. doi: 10.2334/
josnusd.49.253
Rodríguez-Cabrera, M. A., Barona-Dorado, C., Leco-Berrocal, I., Gómez-
Moreno, G., and Martinez-Gonzalez, J. M. (2011). Extractions without
eliminating anticoagulant treatment: a literature review. Med. Oral Patol. Oral
Cir. Bucal 16, e800–e804. doi: 10.4317/medoral.17065
Rowley, C. P., Bernard, M. L., Brabham, W. W., Netzler, P. C., Sidney, D. S.,
Cuoco, F., et al. (2013). Safety of continuous anticoagulation with dabigatran
during implantation of cardiac rhythm devices. Am. J. Cardiol. 111, 1165–1168.
doi: 10.1016/j.amjcard.2012.12.046
Scully, C., Hobkirk, J., and Dios, P. D. (2007). Dental endosseous implants in the
medically compromised patient. J. Oral Rehabil. 34, 590–599. doi: 10.1111/j.
1365-2842.2007.01755.x
Scully, C., and Wolff, A. (2002). Oral surgery in patients on anticoagulant therapy.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 94, 57–64. doi: 10.1067/
moe.2002.123828
Shi, Q., Xu, J., Huo, N., Cai, C., and Liu, H. (2016). Does a higher glycemic level
lead to a higher rate of dental implant failure?: a meta-analysis. J. Am. Dent.
Assoc. 147, 875–881. doi: 10.1016/j.adaj.2016.06.011
Somma, F., Grande, N. M., Plotino, G., Cameli, G., and Pameijer, C. H. (2010).
Conservative approach to dental extractions in patients on anticoagulant
therapy: a clinical study. Gen. Dent. 58, e30–e35.
Svensson, R., Hallmer, F., Englesson, C. S., Svensson, P. J., and Becktor, J. P.
(2013). Treatment with local hemostatic agents and primary closure after tooth
extraction in warfarin treated patients. Swed. Dent. J. 37, 71–77.
Wells, G., Shea, B., O’connell, D., Peterson, J., Welch, V., Losos, M., et al. (2013).
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomised
Studies in Meta-Analyses [Online]. Available at: http://www.ohri.ca/programs/
clinical_epidemiology/oxford.asp
Zanon, E., Martinelli, F., Bacci, C., Cordioli, G., and Girolami, A. (2003).
Safety of dental extraction among consecutive patients on oral anticoagulant
treatment managed using a specific dental management protocol. Blood Coagul.
Fibrinolysis 14, 27–30. doi: 10.1097/00001721-200301000-00006
Zirk, M., Fienitz, T., Edel, R., Kreppel, M., Dreiseidler, T., and Rothamel, D. (2016).
Prevention of post-operative bleeding in hemostatic compromised patients
using native porcine collagen fleeces—retrospective study of a consecutive case
series. Oral Maxillofac. Surg. 20, 249–254. doi: 10.1007/s10006-016-0560-7
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Shi, Xu, Zhang, Zhang and Liu. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Pharmacology | www.frontiersin.org 11 February 2017 | Volume 8 | Article 58
